p53 and redox state in etoposide-induced acute myeloblastic leukemia cell death

Leukemia Research

Volumn 25, Issue 12, 2001, Pages 1099-1105

  Koistinen, Pirjo ^a   Siitonen, Timo ^a   Mäntymaa, Pentti ^b   Savolainen, Eeva Riitta ^a  

^a UNIVERSITY OF OULU   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

AML; Apoptosis; Etoposide; p53; Redox state

Indexed keywords

DYE; ETOPOSIDE; LIPOCORTIN 5; MUTANT PROTEIN; PEROXIDE; PROTEIN P53;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL CLONE; CELL DEATH; CONTROLLED STUDY; DRUG EXPOSURE; DRUG MECHANISM; DRUG RESPONSE; DRUG SENSITIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; ETOPOSIDE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MUTATION; OXIDATION-REDUCTION; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN CONFORMATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034782735     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00076-5     Document Type: Article

References (53)

1. Inhibition of both etoposide-induced DNA fragmentation and activation of poly(ADPribose) synthesis by zinc ion
2. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes
3. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
4. Participation of p53 protein in the cellular response to DNA damage
5. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents
6. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
7. Database of p53 gene somatic mutations in human tumors and cell lines
8. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents
9. Hypersensitivity of human testicular tumors to etoposide induced apoptosis is associated with functional p53 and high bax:bcl-2 ratio
10. Expression of wild-type p53 increases etoposide cytotoxicity in M1 myeloid leukemia cells by facilitated G2 to M transition: Implications for gene therapy
11. Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells
12. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents
13. The tumor suppressor protein p53: A receptor to genotoxic stress that controls cell growth and survival
14. How phosphorylation regulates the activity of p63
15. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli
16. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
17. An oxidative stress-mediated death pathway in irridiated human leukemia cells mapped using multilaser flow cytometry
18. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium
19. Glutathione-associated enzymes in anticancer drug resistance
20. Modulation of glutathione and related enzymes in reversal of resistance to anticancer drugs. Drug resistance
21. Protective roles of cytokines against radiation: Induction of mitochondrial MnSOD
22. Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNF-alpha-induced cell death
23. Lipid peroxides in the olychemotherapy of cancer patients
24. A role for metals and free radicals in the induction of apoptosis in thymocytes
25. Tyrosinase-induced phenoxyl radicals of etoposide (VP-16): Interaction with reductants in model systems, K562 leukemic cell and nuclear homogenates
26. Ascorbate is the primary reductant of the phenoxyl radical of etoposide in the presence of thiols both in cell homogenates and in model systems
27. Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production
28. Protection of acute myeloblastic leukemia cells against apoptotic cell death by high glutathione and gamma-glutamylcysteine synthetase levels during etoposide-induced oxidative stress
29. Induction of mitochondrial manganese superoxide dismutase confers resistance to apoptosis in acute myeloblastic leukaemia cells exposed to etoposide
30. Expression of a retinoic acid receptor gene in myeloid leukemia cells
31. An association between mitochondrial function and all-trans retinoic acid-induced apoptosis in acute myeloblastic leukemia cells
32. p53 status of newly established acute myeloid leukaemia cell lines
33. Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics
34. Phenoxyl radicals of etoposide (VP-16) can directly oxidize intracellular thiols: Protective versus damaging effects of phenolic antioxidants
35. Antioxidant paradoxes of phenolic compounds: Peroxyl redical scavenger and lipid antioxidant, etoposide (VP-16), inhibits sarcoplasmic reticulum Ca(2+)-ATPase via thiol oxidation by its phenoxyl radical
36. Role of peroxide and superoxide anion during tumour cell apoptosis
37. cAMP increasing agents attenuate the generation of apoptosis by etoposide in promonocytic leukemia cells
38. Modulation by D,L-buthionine-S,R-sulfoximine of etoposide cytotoxicity on human non-small cell lung, ovarian and breast carcinoma cell lines
39. Buthionine sulfoximine-mediated sensitation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation
40. Differential induction of transcriptionally active p53 following UV or ionizing irradiation: Defects in chromosome instability syndromes?
41. A functionally inactive p53 protein in embryonal carcinoma cells is activated by DNA damage or cellular differentiation
42. Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells
43. Forms and functions of p53
44. P53, the cellular gatekeeper for growth and division
45. Mutations of the p53 gene in acute myeloid leukemia
46. Mechanisms of p53 alteration in acute leukemias
47. Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells
48. p53 pathway in apoptosis induced by all-trans retinoic acid in acute myeloblastic leukaemia cells
49. A transcriptionally active DNA-binding site for human p53 protein complexes
50. Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage
51. Thymocyte apoptosis induced by p53-dependent and independent pathways
52. p53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs
53. DNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes